FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 347:1368-1371 October 24, 2002 Number 17 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Editorial by Drazen, J. M. Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

"Is the university–industrial complex out of control?" The editorial that appeared under this eye-catching title in Nature in January 2001 came to the conclusion that links between academia and industry are of increasing concern to academics and to society at large and that the sectors involved must review and revise their policies in order to sustain the public accountability and academic freedom of universities.¹ It ended with a list of New Year's resolutions for actions that would be required to maintain public trust in higher education and publicly funded research. But with the notable exception of the decision of many . . . [Full Text of this Article]

The Dispute

Current Status of Deferiprone

The Ethical Struggle

Conclusions

This article has been cited by other articles:

• Laberge, S., Albert, M., Hodges, B. D. (2009). Perspectives of clinician and biomedical scientists on interdisciplinary health research. CMAJ 181: 797-803 [Abstract] [Full Text]  
• Okike, K., Kocher, M. S. (2007). The Legal and Ethical Issues Surrounding Financial Conflict of Interest in Orthopaedic Research. JBJS 89: 910-913 [Full Text]  
• Stossel, T. P. (2005). Regulating Academic-Industrial Research Relationships -- Solving Problems or Stifling Progress?. NEJM 353: 1060-1065 [Full Text]  
• Mello, M. M., Clarridge, B. R., Studdert, D. M. (2005). Academic Medical Centers' Standards for Clinical-Trial Agreements with Industry. NEJM 352: 2202-2210 [Abstract] [Full Text]  
• Williams-Jones, B. (2005). Knowledge commons or economic engine - what's a university for?. J. Med. Ethics 31: 249-250 [Full Text]  
• Schafer, A (2004). Biomedical conflicts of interest: a defence of the sequestration thesis--learning from the cases of Nancy Olivieri and David Healy. J. Med. Ethics 30: 8-24 [Abstract] [Full Text]  
• Baylis, F (2004). The Olivieri debacle: where were the heroes of bioethics?. J. Med. Ethics 30: 44-49 [Abstract] [Full Text]  
• Blumenthal, D. (2003). Academic-Industrial Relationships in the Life Sciences. NEJM 349: 2452-2459 [Full Text]  
• Nathan, D. G., Wilson, J. D. (2003). Clinical Research and the NIH -- A Report Card. NEJM 349: 1860-1865 [Full Text]  
• Zuess, J. (2003). Complementary and Alternative Medicine and Mental Health Care: Shared Challenges. Complementary Health Practice Review 8: 193-197  
• Chopra, S. S. (2003). Industry Funding of Clinical Trials: Benefit or Bias?. JAMA 290: 113-114 [Full Text]  
• Baird, P. (2003). Getting it right: industry sponsorship and medical research. CMAJ 168: 1267-1269 [Full Text]  
• Tobin, M. J. (2003). Conflicts of Interest and AJRCCM: Restating Policy and a New Form to Upload. Am. J. Respir. Crit. Care Med. 167: 1161-1164 [Full Text]  
• Constantinou, G., Melides, S., Modell, B., Spino, M., Tricta, F., Nathan, D. G., Weatherall, D. J. (2003). The Olivieri Case. NEJM 348: 860-863 [Full Text]